Crossmark

Formulation Development, Optimization by Box-Behnken Design, and In Vitro Characterization of Gefitinib Phospholipid Complex Based Nanoemulsion Drug Delivery System

Crossref DOI link: https://doi.org/10.1007/s12247-022-09690-6

Published Online: 2022-11-14

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohit,

Kumar, Pankaj

Solanki, Pavitra

Mangla, Bharti

Aggarwal, Geeta
License Information

Text and Data Mining valid from 2022-11-14

Version of Record valid from 2022-11-14
More Information

Article History

Accepted: 4 October 2022

First Online: 14 November 2022

Declarations

:

: This research does not contain any study related to human and animals.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below